Hearing loss affects over 1.5 billion people worldwide, isolating them from conversations, connections, and the full experience of life. Sonova exists to change that reality - pioneering innovative hearing care solutions that restore the vital human sense of hearing and enable people to live without limitations. Since 1947, the company has grown from a Swiss startup into a global leader, developing cutting-edge hearing aids, cochlear implants, wireless communication systems, and audiological care services that transform millions of lives annually.
Operating through four strategic business segments - Hearing Instruments, Audiological Care, Consumer Hearing, and Cochlear Implants - Sonova reaches customers in over 100 countries through its house of brands including Phonak, Unitron, AudioNova, Sennheiser (under license), and Advanced Bionics. The company's 18,000+ employees drive this mission forward, backed by over 1,800 patents and design rights. In the 2024/25 financial year, Sonova generated CHF 3.9 billion in sales with a net profit of CHF 547 million, demonstrating both strong business performance and unwavering commitment to its vision: a world where everyone enjoys the delight of hearing.